The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: A randomized controlled clinical trial
Abstract
Objectives Anti-inflammatory therapeutic approaches are considered for the management of type 2 diabetes and for the prevention of its complications. There is limited evidence regarding the effects of prebiotics on inflammation, especially in patients with type 2 diabetes. This trial aims to examine the effects of oligofructose-enriched inulin on glycemic status, inflammation markers, and metabolic endotoxemia in female patients.Methods Over a period of 8 wk, 52 women with body mass indices of >25 kg/m(2) but <35 kg/m(2) with type 2 diabetes were randomly assigned to either an intervention group, in which participants were given oligofructose-enriched inulin (n = 27, consuming 10 g/d of oligofructose-enriched inulin), or to a control group, in which participants were given maltodextrin (n = 25, consuming 10 g/d of maltodextrin). Fasting plasma glucose, glycosylated hemoglobin, high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-α, interferon-γ, interleukin-10, and plasma lipopolysaccharide were measured before and after the intervention. Data were analyzed with the use of SPSS software version 13. Paired and unpaired Student t tests and analysis of covariance were used to compare quantitative variables.Results Oligofructose-enriched inulin caused a significant decrease in the levels of fasting plasma glucose (19.2 mg/dL; 9.50%), glycosylated hemoglobin (1.0%; 8.40%), interleukin-6 (1.3 pg/mL; 8.15%), tumor necrosis factor-α (3.0 pg/mL; 19.80%) and plasma lipopolysaccharide (6.0 EU/mL; 21.95%) as compared with maltodextrin (P < 0.05). Decreases in levels of interferon-γ (0.3 pg/mL; 16.50%) and high-sensitivity C-reactive protein (3.9 ng/mL; 31.70%) and an increase in the level of interleukin-10 (0.4 pg/mL, 11.50%) were not significant in the oligofructose-enriched inulin group as compared with the maltodextrin group.Conclusions In women with type 2 diabetes and suboptimal daily dietary fiber intake, oligofructose-enriched inulin may help to modulate some inflammatory markers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have demonstrated a significant increase in short-chain fatty acids (SCFA), with prebiotic use additionally supporting increased Bifidobacteria growth, and decreased levels of bacteriodes and Fermicutes phyla [57,58,59,60,61].”
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,094
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,918
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518
Cani, P. D., Neyrinck, A. M., Fava, F., Knauf, C., Burcelin, R., Tuohy, K. M., Gibson, G. R., & Delzenne, N. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0791-0 · Cited by 1,770
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s5 · Cited by 1,690
Clinical trials: A practical approach
Daly, M. J. (1984) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(84)90515-7 · Cited by 1,057
Creely, S. J., McTernan, P. G., Kusminski, C. M., Fisher, F. M., Da Silva, N. F., Khanolkar, M., Evans, M., Harte, A. L., & Kumar, S. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00302.2006 · Cited by 1,043
The role of the gut microbiota in energy metabolism and metabolic disease
Cani, P., & Delzenne, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168164 · Cited by 974
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–207 of 207
Mahmoudi, R., Nabaee, M., Kooshki, A., Yazdi, S. S., Neamatshahi, M., & Foroumandi, E. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332029
Case studies and real-world applications
Chellammal, H. S. J., Padiyar, A., Kumaar, I. M., Shaikh, N. K., Limani, G. N., Angirekula, N., Akram, W., & Aher, V. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36617-8.00009-5
Vajdi, M., Khorvash, F., Rouhani, M. H., Ghavami, A., Clark, C. C. T., & Askari, G. (2024) · Figshare · doi:10.6084/m9.figshare.26638800
Zongo, L., Bonkoungou, P., Tiendrebeogo, M. B. T., Ouedraogo, S., OUEDRAOGO, M. W., Zongo, M., CANFUA, R. R., Lange, H., Ouedraogo, A. K., Zohoncon, T. M., et al. (2026) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2026.142015
Métabolomique permettant la découverte de biomarqueurs pertinents
Rezig, L. (2016) · theses.fr (ABES) · doi:10.70675/7b02aedbzd20cz46fbzb0a9zdecf28d88809
Nutrition as a Keystone of Balanced Physiology—Harnessing Human and Microbial Metabolic Synergy
Kumar, S., & Spiteri, C. (2026) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-032-32838-0_10
Metadata
- Authors
- Dehghan, P., Pourghassem Gargari, B., & Asghari Jafar-abadi, M.
- Affiliations
- Tabriz University of Medical Sciences (IR)
- ORCID
- Dehghan, Parvin
- Venue
- Nutrition
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 30
- Issue
- 4
- Pages
- 418-423
- ISSN
- 0899-9007 (ISSN-L)
- OpenAlex
- W1977968392
- Cited by
- 207
- References
- 43
- Citations by year
- 2026: 5 · 2025: 22 · 2024: 18 · 2023: 12 · 2022: 38 · 2021: 13 · 2020: 14 · 2019: 25 · 2018: 12 · 2017: 15 · 2016: 13 · 2015: 15 · 2014: 4
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Tabriz
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- oligofructose-enriched inulin, prebiotics, type 2 diabetes, women, inflammatory markers, endotoxemia, lipopolysaccharide, glycemic control, HbA1c, fasting blood glucose, interleukin-6, TNF-α, C-reactive protein, IL-10, interferon-gamma
- MeSH terms
- Adult, Blood Glucose, C-Reactive Protein, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Inflammation, Interferon-gamma, Inulin, Lipopolysaccharides, Middle Aged, Oligosaccharides, Tumor Necrosis Factor-alpha, Biomarkers, Interleukin-6, Body Mass Index, Endotoxemia, Prebiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review